Who Owns Aquestive Therapeutics Stock?
NASDAQ: AQSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 3:58 PM ET
Ownership breakdown
- Held by institutions
- 58.39%
- Held by insiders
- 2.77%
- Institutional holders
- 240
- Institutions 58.4%
- Insiders 2.8%
- Public and other 38.8%
Who owns Aquestive Therapeutics stock?
Institutional investors own about 58.4% of Aquestive Therapeutics's shares, spread across 240 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 2.77% of AQST.
The largest institutional holders are Bratton Capital Management, LP (7.82%), Blackrock Inc. (6.43%) and RTW Investments LP (5.92%). Together, the top 10 institutions control 35.2% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their AQST positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AQST
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Bratton Capital Management, LP | 9.81M | 7.82% | 0.0% |
| Blackrock Inc. | 8.07M | 6.43% | +7.5% |
| RTW Investments LP | 7.43M | 5.92% | 0.0% |
| Vanguard Capital Management LLC | 4.58M | 3.65% | +3.2% |
| Federated Hermes, Inc. | 3.11M | 2.48% | +5.9% |
| State Street Corporation | 2.93M | 2.33% | +15.0% |
| Geode Capital Management, LLC | 2.62M | 2.09% | +8.9% |
| Samsara BioCapital, LLC | 2.50M | 1.99% | 0.0% |
| Bank of America Corporation | 1.67M | 1.33% | -30.6% |
| Sio Capital Management, LLC | 1.49M | 1.18% | -22.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AQST
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.40M | 2.71% |
| iShares Trust-iShares Russell 2000 ETF | 2.78M | 2.21% |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund | 1.39M | 1.11% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.17M | 0.93% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.08M | 0.86% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 1.07M | 0.85% |
| Bridge Builder Trust-Bridge Builder Small/Mid Cap Growth Fund | 740.70K | 0.59% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 732.97K | 0.58% |
| WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund | 719.41K | 0.57% |
| WASATCH FUNDS TRUST-Wasatch Micro Cap Fund | 642.48K | 0.51% |
Frequently asked questions
Who is the largest shareholder of Aquestive Therapeutics?
Bratton Capital Management, LP is the largest institutional shareholder of AQST, owning 7.82% of shares outstanding (9.81M shares) as of its latest 13F filing.
What percentage of Aquestive Therapeutics is owned by institutions?
Institutions own about 58.4% of AQST shares and 60.1% of the public float.
How much of Aquestive Therapeutics do insiders own?
Insiders, such as officers and directors, own about 2.77% of AQST shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.